top of page

Global AI Competitiveness Index Part 6  Infographics

Global Artificial Intelligence Competitiveness Index 6th Edition Companies Landscape Overview 2026

AI in BioTech, Healthcare & Longevity Ecosystem Global banner.png

Global Artificial Intelligence Competitiveness Index 6th Edition Infrastructure Projects Overview 2026 

Screenshot 2026-05-11 at 14.20.10.png

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity

Country Index: Top 20 AI-Biomedical Systems

National Scores by Index Pillar

Case Studies: How Biomedical AI Ecosystems Are Built

National Scores by Index Pillar

The country index evaluates national competitiveness across eight pillars: scientific and research infrastructure; AI capability in biotech and drug discovery; healthcare system digital readiness; data availability, quality, and accessibility; regulatory readiness and governance capacity.

Pillar 1: Scientific & Research Infrastructure (Sci)
Pillar 2: AI Capability in Biotech & Drug Discovery (BioAI)
Pillar 3: Healthcare System Digital Readiness (Health Dig)
Pillar 4: Data Availability, Quality & Accessibility (Data)

Pillar 5: Regulatory Readiness & Governance Capacity (Reg)
Pillar 6: Capital Formation & Investment Ecosystem (Capital)
Pillar 7: Talent & Human Capital (Talent)
Pillar 8: Longevity & Preventive Health Innovation (Longevity)

Cumulative National Scores Across All Editions (Global AI Competitiveness Index)

Screenshot 2026-05-12 at 15.03.43.png
Screenshot 2026-05-12 at 15.03.54.png

Global AI Competitiveness Index Part 6: Country Benchmark: What Separates the Leaders

Comparison of AI Competitiveness Across Pillars

Research AI, Clinical AI, and Commercial Deployment AI: Country Level of AI Competitiveness (BioTech, Healthcare, Longevity)

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity

City and Innovation Hub Index: Top 20 AI-Biomedical Systems

City-Hub Scores by Pillar

Case Studies: How Biomedical AI Ecosystems Are Built

Screenshot 2026-05-11 at 16.03.31.png
Screenshot 2026-05-11 at 16.07.29.png
Screenshot 2026-05-11 at 16.59.37.png

City-Hub Scores by Pillar

Biomedical AI capability concentrates strongly at city and hub level. The hub index therefore benchmarks metro-scale ecosystems where research hospitals, universities, biotech firms, investors, data environments, and deployment partners are tightly clustered. 

Winning hubs are not only places with strong science. They are places where the elements of biomedical AI deployment are close enough to reinforce one another.


Pillar 1: Research & Clinical Cluster Strength (Research & Clinica)
Pillar 2: Biotech AI & Translational Density (BioTech & AI)
Pillar 3: Data/Deployment Environment (Data/Deploy)
Pillar 4: Capital Formation & Markets (Capital)
Pillar 5: Talent Magnet & Interdisciplinary Density (Talent)
Pillar 6: Longevity/Prevention Ecosystem Maturity (Longevity)

Global AI Competitiveness Index Part 6: Capital Formation and Investment Ecosystems

Distribution of capital Investment in Biotech and Healthtech Ventures

Number of AI Companies in Healthcare BioTech and Longevity Categories

Global AI Competitiveness Index Part 6: AI in Healthcare Systems, BioTech Innovation & AI Infrastructure

Global AI Competitiveness Index Part 6 measures the transition from discovery to deployment. Research AI focuses on hypothesis generation, target discovery, molecular design, biomarker identification, and large-scale biological analysis. Clinical AI moves into patient care, diagnostics, clinical decision support, imaging, trial design, and hospital workflows. 

The most competitive countries and hubs are those that reduce friction across all three stages. This is the practical meaning of deployment-readiness: not simply building AI models, but creating the institutional, data, regulatory, and capital conditions that allow AI-enabled biomedical systems to function safely and repeatedly in the real world.


 

Global AI Competitiveness Index Part 6: The Data Layer: From Clinical Records to Real-World Evidence

AI in Clinical Trials: Enhancing Patient Recruitment, Trial Design, and Real-Time Decision Making

Public vs Private Companies in Healthtech and Biotech sectors

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity Ecosystem Overview

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity Ecosystem Overview

 

Welcome to the 3D Metaverse Interactive Map, a cutting-edge digital platform highlighting the global AI competitiveness in the BioTech, Healthcare, and Longevity sectors. Navigate an immersive map that presents detailed locations and profiles of pioneering companies leading advancements in healthcare, biotechnology, and aging research worldwide. This tool allows users to uncover key players, explore their contributions, and connect with a thriving global healthcare community, driving innovation and fostering collaboration in these transformative industries.



 

    3D Metaverse Interactive Map of Global AI Competitiveness Index AI in BioTech, Healthcare and Longevity Ecosystem





 

ai-health-global-infrastructure-projects.png

 

The Global AI in BioTech, Healthcare, and Longevity Ecosystem is brought to life with an interactive 3D Tube visualization. This dynamic cylindrical view emphasizes the interconnections between key infrastructure projects, allowing users to explore the global AI-driven biomedicine landscape in detail. The platform highlights crucial initiatives in the field, offering valuable insights into the collaborative advancements propelling the future of healthy aging, lifespan extension, and AI-powered longevity research across the globe.

 

    3D Interstellar Map of Global AI Competitiveness Index AI in BioTech, Healthcare and Longevity Infrastructural Projects



 

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity Ecosystem Overview

Global AI Competitiveness Index Part 6: AI in BioTech, Healthcare and Longevity Ecosystem Overview

bottom of page